PCSK9 and familial hypercholesterolemia: Another important risk modifier is familial hypercholesterolemia, which is caused by functional mutations in the LDL receptor, apolipoprotein B, or Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) genes [2].